Mutations in intron 3 of GH‐1 gene associated with isolated GH deficiency type II in three Japanese families
- 1 September 1999
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 51 (3) , 355-360
- https://doi.org/10.1046/j.1365-2265.1999.00798.x
Abstract
OBJECTIVE Isolated GH deficiency (IGHD) type II is a disorder inherited in an autosomal dominant manner. Three mutations at the donor splice site of intron 3 of the GH‐I gene have been identified in five families. In this report, we describe a novel mutation also at the donor splice site of intron 3 in patients with IGHD type II. PATIENTS Five individuals diagnosed as IGHD: two sporadic cases and one family with three affected individuals (two siblings and their father). MEASUREMENT Genomic DNA was extracted from peripheral mononuclear cells. All the exons and introns of the GH‐I gene were amplified by polymerase chain reaction (PCR) and subjected to sequence analysis. RESULTS A guanine to adenine transition at the fifth base of intron 3 (mutE), which has not been reported, was identified in the familial case but not in unaffected members of the family including the paternal grandparents. In the other two families with sporadic cases, a guanine to adenine transition at the first base of intron 3 (mutA) was identified in the affected subjects but not in other members of the families. CONCLUSION MutE has not been previously reported and is the fourth mutation associated with IGHD type II. The guanine residue mutated in mutA was the second nucleotide of a CpG dinucleotide, which is regarded as a hot spot for mutations by a methylation‐deamination mechanism. Since mutA has previously been identified in three type II IGHD kindreds belonging to different ethnic backgrounds, this appears to be the most frequent GH‐I gene mutation in IGHD with a dominant inheritance. Because de novo mutations appeared to have occurred in all three families analyzed in the present study and the presence or absence of these mutations can easily be tested by PCR and restriction enzyme digestion, not only the familial cases but also sporadic cases with IGHD should be examined for a possible mutation at the donor splice site of intron 3 in the GH‐1 gene.Keywords
This publication has 10 references indexed in Scilit:
- Inhibition of Growth Hormone (GH) Secretion by a Mutant GH-I Gene Product in Neuroendocrine Cells Containing Secretory Granules: An Implication for Isolated GH Deficiency Inherited in an Autosomal Dominant MannerJournal of Clinical Endocrinology & Metabolism, 1999
- A Splicing Variant of Steroid Receptor Coactivator-1 (SRC-1E): The Major Isoform of SRC-1 to Mediate Thyroid Hormone ActionBiochemical and Biophysical Research Communications, 1997
- A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center studyJournal of Clinical Endocrinology & Metabolism, 1995
- Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysisJournal of Clinical Endocrinology & Metabolism, 1995
- Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric proteinJournal of Clinical Endocrinology & Metabolism, 1994
- Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiencyJournal of Clinical Endocrinology & Metabolism, 1994
- Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification productsJournal of Clinical Endocrinology & Metabolism, 1992
- Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification productsJournal of Clinical Endocrinology & Metabolism, 1992
- The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictionsHuman Genetics, 1990
- Restriction sites containing CpG show a higher frequency of polymorphism in human DNACell, 1984